| Product NDC: | 68258-8961 | 
| Proprietary Name: | SEREVENT | 
| Non Proprietary Name: | salmeterol xinafoate | 
| Active Ingredient(s): | 50 ug/1 & nbsp; salmeterol xinafoate | 
| Administration Route(s): | ORAL; RESPIRATORY (INHALATION) | 
| Dosage Form(s): | POWDER, METERED | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 68258-8961 | 
| Labeler Name: | Dispensing Solutions, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA020692 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 19971125 | 
| Package NDC: | 68258-8961-6 | 
| Package Description: | 60 POWDER, METERED in 1 INHALER (68258-8961-6) | 
| NDC Code | 68258-8961-6 | 
| Proprietary Name | SEREVENT | 
| Package Description | 60 POWDER, METERED in 1 INHALER (68258-8961-6) | 
| Product NDC | 68258-8961 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | salmeterol xinafoate | 
| Dosage Form Name | POWDER, METERED | 
| Route Name | ORAL; RESPIRATORY (INHALATION) | 
| Start Marketing Date | 19971125 | 
| Marketing Category Name | NDA | 
| Labeler Name | Dispensing Solutions, Inc. | 
| Substance Name | SALMETEROL XINAFOATE | 
| Strength Number | 50 | 
| Strength Unit | ug/1 | 
| Pharmaceutical Classes | Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |